# Observing the Real-world Non-interventional Study of Abiraterone Acetate Tablets (II) in Treating Chinese Patients With Metastatic Prostate Cancer

> **NCT07721532** · — · ACTIVE_NOT_RECRUITING · sponsor: **The Affiliated Nanjing Drum Tower Hospital of Nanjing University Medical School** · enrollment: 3000 (estimated)

## Conditions studied

- Diagnosed With Metastatic Prostate Cancer

## Interventions

- **DRUG:** abiraterone acetate tablets (II)

## Key facts

- **NCT ID:** NCT07721532
- **Lead sponsor:** The Affiliated Nanjing Drum Tower Hospital of Nanjing University Medical School
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** ACTIVE_NOT_RECRUITING
- **Start date:** 2025-01-08
- **Primary completion:** 2027-12-21
- **Final completion:** 2027-12-21
- **Target enrollment:** 3000 (ESTIMATED)
- **Last updated:** 2026-07-23

## Collaborators

- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07721532

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07721532, "Observing the Real-world Non-interventional Study of Abiraterone Acetate Tablets (II) in Treating Chinese Patients With Metastatic Prostate Cancer". Retrieved via MORVS 2026-10-20 from https://api.morvs.ai/clinical/NCT07721532. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*